Well yea and there are many strings to Avacta's bow (see energyshares post earlier)
But the lead pre|CISION drug is in the clinic and we should very shortly get some results. If successful so far it not only proves AVA6000 but the entire platform. Should be worth billions hence the focus.
They've never RNS'd a hospital starting to recruit yet. Could be that one of the brave heroic participants has sadly passed away so they need to expand the pool for a new cohort 4 member. We just don't know until they tell us.